Dataset Information

The effectiveness of educational intervention for performing colorectal cancer screening

ABSTRACT: Intervention 1: One group in the study will receive educational intervention. Educational content provided to the intervention group includes an app that is designed based on preventive health model, and an educational pamphlet about colorectal cancer, the importance of screening and a variety of colorectal cancer screening methods. Intervention 2: Control group: One group as a control group will enter the study, that will not receive any training and intervention. Primary outcome(s): Perceived self-efficacy. Timepoint: 2 months after the beginning of the study. Method of measurement: Colorectal screening questionnaire.;Perceived sensitivity. Timepoint: 2 months after the beginning of the study. Method of measurement: Colorectal screening questionnaire.;Worries and fears. Timepoint: 2 months after the beginning of the study. Method of measurement: Colorectal screening questionnaire.;Screening Effectiveness. Timepoint: 2 months after the beginning of the study. Method of measurement: Colorectal screening questionnaire.;Social support. Timepoint: 2 months after the beginning of the study. Method of measurement: Colorectal screening questionnaire.;Behavioral intention. Timepoint: 2 months after the beginning of the study. Method of measurement: Colorectal screening questionnaire. Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Screening, Randomization description: Samples were randomly selected from 2 centers by block sampling method and samples of both groups will be matched based on demographic variables such as age, education, and so on. Random assignment of selected individuals will be done by block random method using quad blocks. For two groups of intervention and comparison use two letters A and B. So the size of each block is twice the number of groups, that is, the number 4. By dividing the sample size by block size, the number of blocks is determined. Sample size is 160 people. Each group consists of 80 people, and the number of blocks in each group is 20 blocks, each of which specifies the assignment of 4 individuals. Finally, all letters A and B are separated, and each person who is not the researcher, by lot, will be suspended by each letter in a group. For example, A intervention group

DISEASE(S): Malignant Neoplasm Of Rectosigmoid Junction,Colorectal Cancer

PROVIDER: 2497407 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Similar Datasets

Project description:Intervention 1: Stinging nettle tablet, produced in the company of barijessence, 400 mg tablet, three times a day for 3 months in intervention group. Intervention 2: Placebo, tablets containing starch, produced in Tehran University of Medical Sciences, 400 mg tablet, three times a day for 3 months in control group.;Treatment - Drugs;Placebo;Stinging nettle tablet, produced in the company of barijessence, 400 mg tablet, three times a day for 3 months in intervention group;Placebo, tablets containing starch, produced in Tehran University of Medical Sciences, 400 mg tablet, three times a day for 3 months in control group. Primary outcome(s): Erythrocyte Sedimentation Rate. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: Automation Method (mm/h).;High- sensitivity C- reactive protein. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: It is measured by kit (ELISA methods) and the unit is mg/dl.;Quality of life. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: Inflammatory Bowel Disease Questionnaire-Short Form.;White blood cell. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: Flow cytometry Method (cells/ml).;Superoxide dismutase. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: It is measured by kit (ELISA methods) and the unit is ng/ml.;Platelet. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: Flow cytometry Method (cells/µl).;Fecal calprotectin. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: It is measured by kit (ELISA methods) and the unit is µg/g.;Tumor necrosis factor alpha. Timepoint: At the Beginning of intervention and 3 months after Beginning of the intervention. Method of measurement: It is measured by kit (ELISA methods) and the unit is ng/ml. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Randomization is done by stratified blocked randomization. Placebo in the form of a double-blind to the participants in this study given. Researchers and patients are blinded to the treatment and placebo groups.

Project description:Intervention 1: Intervention group1: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet, film and free access to fecal occult blood test. Intervention 2: Intervention group2: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet and film. Intervention 3: Intervention group3: free access to fecal occult blood test. Intervention 4: Control group: For the control group will not perform any of the action that will be taken for the intervention group.;Prevention;Prevention;Prevention;Prevention;Intervention group1: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet, film and free access to fecal occult blood test;Intervention group2: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet and film;Intervention group3: free access to fecal occult blood test;Control group: For the control group will not perform any of the action that will be taken for the intervention group. Primary outcome(s): Perceived severity. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Knowledge. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Perceived susceptibility. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Intention. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Perceived barriers. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Social support. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Self efficacy. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Perceived benefits. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire. Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Screening.

Project description:Intervention 1: Intervention group: Family members of the colon cancer patients who will be trained in attendance at the training sessions organized by the presenter. The two-week training session will be held for 1.5 hours with a two-week interval, the contents of the protocols’ training sessions are based on the results of the research and are based on authoritative references and books on colon cancer and approved by the Oncology Department of the University where the project was implemented. Also, answering the questions of patients in specialized medical fields will be done with an oncologist’s consultation and the result will be announced to them. Intervention 2: Control group: Family members of patients with colon cancer who undergo routine training provided by health center staff. Primary outcome(s): Supportive care needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: A Survey of Supporting Care Needs Assessment Questionnaire(SCNS P&C39).;Health system & information needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: Health system & information dimension of SCNS-P&C39.;Psychological needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: Psychological dimension of SCNS-P&C39.;Job and social needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: Job and social dimension of SCNS-P&C39. Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Caregivers who have the conditions for participation in the study are included in the target (accessible or simple) sampling and will be randomly assigned as blocks in the intervention (A) and control (B) group. First, 15 blocks of four are defined as follows:ABAB, BBAA, BABA, BAAB, AAAB, ABBA, etc., and then these blocks are arranged randomly and individuals in A and B will be placed in two groups of intervention and control; this will continue until the sample size is completed. Family member A will be placed in the control group and B will be in the control group so that the sequence of samples will be random.After explaining the goals of the study and how the plan will be done for the patient and the family caring for them, oral consent will be given to them for participation in the study. Researchers will be assured that their infor

Project description:Intervention 1: Intervention group: Participants in the intervention group will receive a Mediterranean diet menu. For this purpose, the energy required by the patients in the intervention group, according to the recommendations of the ASPEN guideline, is first considered 25 kcal per kg of body weight (current weight of patients), and then gradually over two weeks, this amount will be considered up to 35 kcal per kg of body weight. This calorie will be divided as follows: 35% of calories from fat, 45% of calories from carbohydrates, and 20% of calories from protein. Then, the sources of these macronutrients from different food groups will be considered based on the Mediterranean diet pyramid. Moreover, based on these food groups, a weekly menu will be set up for patients. To follow this diet, extra virgin olive oil will be given to patients. Intervention 2: Control group: Participants in the control group will receive nutritional advice for cancer patients and dietary recommendations for weight gain. Primary outcome(s): Nutritional status score. Timepoint: Before the intervention - 8 weeks after the intervention. Method of measurement: PG-SGA (Patient Generated-Subjective Global Assessment) questionnaire.;Muscle strength. Timepoint: Before the intervention - 8 weeks after the intervention. Method of measurement: Handgrip strength dynamometer.;Muscle mass. Timepoint: Before the intervention - 8 weeks after the intervention. Method of measurement: Bio-Electrical Impedance Analysis (BIA).;Inflammatory markers (hs-CRP, IL-6, TNF-a). Timepoint: Before the intervention - 8 weeks after the intervention. Method of measurement: enzyme-linked immunosorbent assay (ELISA). Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Stratified block randomization will be performed based on the type of cancer (colon or rectum) using the site www.randomization.com. In this method, each group will be assigned one of the letters A and B, and randomization will be done in 4 blocks. This will be done for each type of cancer (colon or rectum) and two lists will be prepared for them. Within each class, patients will be randomly assigned to one of the two study groups in a 1: 1 ratio. The randomization process will be performed by someone outside the research team.

Dataset Information

The effectiveness of educational intervention for performing colorectal cancer screening

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets